Medical Therapy for Advanced Pancreatic Cancer: Work in Progress

  • Raffaele Pezzilli Pancreas Unit, Department of Digestive Diseases and Internal Medicine, Sant’Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna. Bologna, Italy
  • Roberto Corinaldesi Pancreas Unit, Department of Digestive Diseases and Internal Medicine, Sant’Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna. Bologna, Italy
  • Antonio Maria Morselli-Labate Pancreas Unit, Department of Digestive Diseases and Internal Medicine, Sant’Orsola-Malpighi Hospital, Alma Mater Studiorum, University of Bologna. Bologna, Italy
Keywords: Acidosis, Lactic, Drug Resistance, Neoplasm, Pancreatic Neoplasms, Pathology, Clinical, Renin-Angiotensin System, Therapeutics

Downloads

Download data is not yet available.

References

Kang SP, Saif MW. Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapy. JOP. J Pancreas (Online) 2008; 9:251-66. [PMID 18469437]

Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009; 324:1457-61. [PMID 19460966]

Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 2009; 16:259-66. [PMID 19732725]

Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors. Cancer Res 1989; 49:6449-65. [PMID 2684393]

Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997; 3:177-82. [PMID 9018236]

Warburg O. On the origin of cancer cells. Science 1956; 123:309-314. [PMID 13298683]

Ager EI, Neo J, Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008; 29:1675-84. [PMID 18632755]

Khakoo AY, Sidman RL, Pasqualini R, Arap W. Does the rennin angiotensin system participate in regulation of human vasculogenesis and angiogenesis? Cancer Res 2008; 68:9112-5. [PMID 19010879]

Noguchi R, Yoshiji H, Ikenaka Y, Namisaki T, Kitade M, Kaji K, et al. Synergistic inhibitory effect of gemcitabine and angiotensin type-1 receptor blocker, losartan, on murine pancreatic tumor growth via antiangiogenic activities. Oncol Rep 2009; 22:355-60. [PMID 19578777]

Amaya K, Ohta T, Kitagawa H, Kayahara M, Takamura H, Fujimura T, et al. Angiotensin II activates MAP kinase and NF-kappaB through angiotensin II type I receptor in human pancreatic cancer cells. Int J Oncol 2004; 25:849-6. [PMID 15375532]

Gong Q, Davis M, Chipitsyna G, Yeo CJ, Arafat HA. Blocking angiotensin II type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells. Pancreas 2010; 39:581-94. [PMID 20118823]

Pezzilli R, Corinaldesi R, Morselli-Labate A. Pancreatic cancer and cancer screening programs: from nihilism to hope. JOP. J Pancreas (Online) 2010; 11:654-5. [PMID 21068511]

Singh S, Srivastava SK, Bhardwaj A, Owen LB, Singh AP. CXCL12-CXCR4 signaling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy. British J Cancer 2010; 103:1671-9. [PMID 21045835]

Fukamachi T, Chiba Y, Wanga X, Saito H, Tagawa M, Kobayashi H. Tumor specific low pH environments enhance the cytotoxicity of lovastatin and cantharidin. Cancer Lett 2010; 297:182-9. [PMID 20831979]

Nakai Y, Isayama H, Ijichi H, Sasaki T, Sasahira N, Hirano K, et al. Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. British J Cancer 2010; 103:1644-8. [PMID 20978506]

Pancreas News
Published
2011-01-05
How to Cite
PezzilliR., CorinaldesiR., & Morselli-LabateA. (2011). Medical Therapy for Advanced Pancreatic Cancer: Work in Progress. JOP. Journal of the Pancreas, 12(1), 72-73. https://doi.org/10.6092/1590-8577/3393
Section
PANCREAS NEWS